Antiresorptive-related osteonecrosis of the jaw (ARONJ) is a rare but serious adverse event of bisphosphonate or denosumab administration; it is associated with severe pain and a deteriorated quality of life. Since its first report in 2003, there have been many studies on its definition, epidemiology, pathophysiology, diagnosis, and treatment. Nevertheless, the epidemiology and mechanisms underlying this condition have not yet been fully delineated and several risk factors are known. Moreover, as there is no effective treatment currently available for osteonecrosis of the jaw, prevention is essential. Furthermore, close cooperation between prescribing physicians and dentists is important. The aim of this review was to provide up-to-date information regarding the risk factors and prevention of ARONJ from a physician’s perspective.
Citations
Citations to this article as recorded by
Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: Investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents Mitsunobu Otsuru, Yoshinari Fujiki, Sakiko Soutome, Norio Nakamura, Taro Miyoshi, Tomofumi Naruse, Mizuho Ohnuma, Yuka Hotokezaka, Satoshi Rokutanda, Masahiro Umeda Journal of Dental Sciences.2024; 19(1): 203. CrossRef
Editorial: Immunological processes in maxillofacial bone pathology Matthias Tröltzsch Frontiers in Immunology.2024;[Epub] CrossRef
Polysacharide of Agaricus blazei gel mitigates bone necrosis in model of the jaws related to bisphosphonate via Wnt signaling Vanessa Costa de Sousa, Fátima Regina Nunes Sousa, Raquel Felipe Vasconcelos, Gisele Angelino Barreto, Conceição S. Martins, Nilson Romero Dias, Sislana Costa, Maria Jennifer Chaves Bernardino, George de Almeida Silva, Nadine Linhares, Delane Gondim, Mirn Scientific Reports.2024;[Epub] CrossRef
Prevention of medication-related osteonecrosis of the jaw after tooth extraction by local administration of antibiotics and atelocollagen sponge: A preliminary study Natsumi Nakamura, Sakiko Soutome, Akira Imakiire, Satoshi Rokutanda, Seigo Ohba, Shunsuke Sawada, Yuka Kojima, Yuki Sakamoto, Yoshiko Yamamura, Madoka Funahara, Mitsunobu Otsuru, Masahiro Umeda Journal of Dental Sciences.2024;[Epub] CrossRef
When and how to stop denosumab therapy in a patient with osteoporosis Eirena L. Goulden, Rachel K. Crowley Clinical Endocrinology.2023; 98(5): 649. CrossRef
Clinical and Histopathological Aspects of MRONJ in Cancer Patients George Adrian Ciobanu, Laurențiu Mogoantă, Adrian Camen, Mihaela Ionescu, Daniel Vlad, Ionela Elisabeta Staicu, Cristina Maria Munteanu, Mircea Ionuț Gheorghiță, Răzvan Mercuț, Elena Claudia Sin, Sanda Mihaela Popescu Journal of Clinical Medicine.2023; 12(10): 3383. CrossRef
Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects Diana Nogueira, Inês Morais Caldas, Ricardo Jorge Dinis-Oliveira Archives of Oral Biology.2023; 155: 105792. CrossRef
Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid George Adrian Ciobanu, Laurențiu Mogoantă, Sanda Mihaela Popescu, Mihaela Ionescu, Cristina Maria Munteanu, Ionela Elisabeta Staicu, Răzvan Mercuț, Cristian Corneliu Georgescu, Monica Scrieciu, Daniel Vlad, Adrian Camen International Journal of Molecular Sciences.2023; 24(18): 14345. CrossRef
Analysis of the Degree of Information of Dental Surgeons about Antiresorptive Drugs According to the Time Since Graduation in Dentistry Flávia Godinho Costa Wanderley Rocha, Roberto Paulo Correia de Araújo Pesquisa Brasileira em Odontopediatria e Clínica Integrada.2023;[Epub] CrossRef
Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report Stefano Martinelli, Marco Pitea, Italo Francesco Gatelli, Tara Raouf, Graziano Barera, Ottavio Vitelli Frontiers in Pediatrics.2022;[Epub] CrossRef
Zoledronic acid for osteoporosis and associated low-energy fractures S. S. Rodionova, A. F. Kolondaev, A. N. Torgashin, I. A. Solomyannik Meditsinskiy sovet = Medical Council.2022; (21): 163. CrossRef
Osteoporosis is an incurable chronic condition, like heart disease, diabetes, or hypertension. A large gap currently exists in the primary prevention of fractures, and studies show that an estimated 80% to 90% of adults do not receive appropriate osteoporosis management even in the secondary prevention setting. Case finding strategies have been developed and effective pharmacological interventions are available. This publication addresses how best to use the pharmacological options available for postmenopausal osteoporosis to provide lifelong fracture protection in patients at high and very high risk of fracture. The benefit of osteoporosis therapies far outweighs the rare risks.
Citations
Citations to this article as recorded by
Effects of stepwise administration of osteoprotegerin and parathyroid hormone-related peptide DNA vectors on bone formation in ovariectomized rat model Ye Ji Eom, Jang-Woon Kim, Yeri Alice Rim, Jooyoung Lim, Se In Jung, Ji Hyeon Ju Scientific Reports.2024;[Epub] CrossRef
Glycolithocholic acid increases the frequency of circulating Tregs through constitutive androstane receptor to alleviate postmenopausal osteoporosis Xiaoyu Cai, Zhi Li, Yao Yao, Yongquan Zheng, Meng Zhang, Yiqing Ye Biochemical Pharmacology.2024; 219: 115951. CrossRef
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB Tao Yu, Xiao Liu, Meng Jiang, Yuanyue Li, Heng Su, Ben Niu In Vitro Cellular & Developmental Biology - Animal.2024; 60(1): 54. CrossRef
Eupatilin ameliorates postmenopausal osteoporosis via elevating microRNA‐211‐5p and repressing JAK2/STAT3 pathway Liu Hong, Chao Yang Environmental Toxicology.2024; 39(4): 2218. CrossRef
Strontium-Doped Mesoporous Bioactive Glass-Loading Bisphosphonates Inhibit Osteoclast Differentiation and Prevent Osteoporosis in Ovariectomized Mice Zhi Zhou, Shicheng Huo, Zhanchun Li Coatings.2024; 14(1): 97. CrossRef
A novel PDIA3/FTO/USP20 positive feedback regulatory loop induces osteogenic differentiation of preosteoblast in osteoporosis Fei Zhang, Chen Liu, Zhiyong Chen, Chengyi Zhao Cell Biology International.2024; 48(4): 541. CrossRef
Research Progress of Zoledronic Acid in the Treatment of Osteoarthritis 保成 刘 Advances in Clinical Medicine.2024; 14(02): 2821. CrossRef
A novel mechanism of Vildagliptin in regulating bone metabolism and mitigating osteoporosis Jinwen He, Dacheng Zhao, Bo Peng, Xingwen Wang, Shenghong Wang, Xiaobing Zhao, Peng Xu, Bin Geng, Yayi Xia International Immunopharmacology.2024; 130: 111671. CrossRef
Positive benefit-risk ratio of Psoraleae Fructus: Comprehensive safety assessment and osteogenic effects in rats Zhuo Shi, Jin-chao Pan, Yi Ru, Ning-ning Shen, Yu-fu Liu, Cheng Zhang, Xiang-jun Wu, Fang-yang Li, Jia-lu Cui, Chun-qi Yang, Jun-ling Yang, Mao-xing Li, Cheng-rong Xiao, Zeng-chun Ma, Chuan Li, Yu-guang Wang, Yue Gao Journal of Ethnopharmacology.2024; 326: 117967. CrossRef
Function-oriented mechanism discovery of coumarins from Psoralea corylifolia L. in the treatment of ovariectomy-induced osteoporosis based on multi-omics analysis Qianyi Wei, Yongrong Zhou, Zhengtao Hu, Ye Shi, Qing Ning, Keyun Ren, Xinyu Guo, Ronglin Zhong, Zhi Xia, Yinghao Yin, Yongxin Hu, Yingjie Wei, Ziqi Shi Journal of Ethnopharmacology.2024; 329: 118130. CrossRef
Efficacy and Possible Mechanisms of Astragali Radix and its Ingredients
in Animal Models of Osteoporosis: A Preclinical Review and Metaanalysis Ning Cao, Zhangxuan Shou, Yi Xiao, Puqing Liu Current Drug Targets.2024; 25(2): 135. CrossRef
Enhanced oral bioavailability of levormeloxifene and raloxifene by nanoemulsion: simultaneous bioanalysis using liquid chromatography-tandem mass spectrometry Divya Chauhan, Debalina Maity, Pavan K Yadav, Sachin Vishwakarma, Arun Agarwal, Manish K Chourasia, Jiaur R Gayen Nanomedicine.2024;[Epub] CrossRef
Changes in Testing and Treatment Methods in Osteoporosis Care Takashi Nagai, Koji Ishikawa, Koki Tsuchiya, Soji Tani, Yusuke Dodo, Yusuke Oshita, Keizo Sakamoto, Nobuyuki Kawate, Yoshifumi Kudo, Deepak Kumar Khajuria Journal of Osteoporosis.2024; 2024: 1. CrossRef
CircRNA hsa_circ_0006859 inhibits the osteogenic differentiation of BMSCs and aggravates osteoporosis by targeting miR-642b-5p/miR-483-3p and upregulating EFNA2/DOCK3 Peng Yin, Yuan Xue International Immunopharmacology.2023; 116: 109844. CrossRef
Resveratrol induces proliferation and differentiation of mouse pre-osteoblast MC3T3-E1 by promoting autophagy Weiye Cai, Bin Sun, Chao Song, Fei Liu, Zhengliang Wu, Zongchao Liu BMC Complementary Medicine and Therapies.2023;[Epub] CrossRef
Oridonin Attenuates Thioacetamide-Induced Osteoclastogenesis Through MAPK/NF-κB Pathway and Thioacetamide-Inhibited Osteoblastogenesis Through BMP-2/RUNX2 Pathway XiaoLi Jin, Jia Xu, Fanfan Yang, Jin Chen, Feng Luo, Bin Xu, Jian Xu Calcified Tissue International.2023; 112(6): 704. CrossRef
Phytochemical Compounds Involved in the Bone Regeneration Process and Their Innovative Administration: A Systematic Review Alina Hanga-Farcaș, Florina Miere (Groza), Gabriela Adriana Filip, Simona Clichici, Luminita Fritea, Laura Grațiela Vicaș, Eleonora Marian, Annamaria Pallag, Tunde Jurca, Sanda Monica Filip, Mariana Eugenia Muresan Plants.2023; 12(10): 2055. CrossRef
Screening of superior anti‐osteoporotic flavonoids from Epimedii Folium with dual effects of reversing iron overload and promoting osteogenesis Jun Jiang, Jinjin He, Shichang Xiao, Jiayi Shenyuan, Tong Chen, Dan Pei Biomedical Chromatography.2023;[Epub] CrossRef
Study on the Effect of Bushen Zhuanggu Tablet Combined with Conventional Regimen on Bone Mineral Density Improvement, Functional Recovery and Fracture Risk Prevention in Patients with Postmenopausal Osteoporosis Tianliang Chen, Guilan Li, Yongtao Xu, Min Tang Computational and Mathematical Methods in Medicine.2023; 2023: 1. CrossRef
Circ_0001825 promotes osteogenic differentiation in human-derived mesenchymal stem cells via miR-1270/SMAD5 axis Changjun Zheng, Lingzhi Ding, Ziming Xiang, Mingxuan Feng, Fujiang Zhao, Zhaoxin Zhou, Chang She Journal of Orthopaedic Surgery and Research.2023;[Epub] CrossRef
Identification of ROCK1 as a novel biomarker for postmenopausal osteoporosis and pan-cancer analysis Bowen Lai, Heng Jiang, Yuan Gao, Xuhui Zhou Aging.2023; 15(17): 8873. CrossRef
The Mechanotransduction Signaling Pathways in the Regulation of Osteogenesis Zhaoshuo Liu, Qilin Wang, Junyou Zhang, Sihan Qi, Yingying Duan, Chunyan Li International Journal of Molecular Sciences.2023; 24(18): 14326. CrossRef
Decoding the mechanism of Eleutheroside E in treating osteoporosis via network pharmacological analysis and molecular docking of osteoclast-related genes and gut microbiota Tianyu Zhou, Yilin Zhou, Dongdong Ge, Youhong Xie, Jiangyan Wang, Lin Tang, Qunwei Dong, Ping Sun Frontiers in Endocrinology.2023;[Epub] CrossRef
Epigallocatechin gallate alleviates osteoporosis by regulating the gut microbiota and serum metabolites in rats Xuebing Han, Yifeng Fu, Keyu Wang, Siying Li, Chang Jiang, Shuangshuang Wang, Zheng Wang, Gang Liu, Siwang Hu Food & Function.2023; 14(23): 10564. CrossRef
The Molecular Role of Polyamines in Age-Related Diseases: An Update Guadalupe Elizabeth Jimenez Gutierrez, Fabiola V. Borbolla Jiménez, Luis G. Muñoz, Yessica Sarai Tapia Guerrero, Nadia Mireya Murillo Melo, José Melesio Cristóbal-Luna, Norberto Leyva Garcia, Joaquín Cordero-Martínez, Jonathan J. Magaña International Journal of Molecular Sciences.2023; 24(22): 16469. CrossRef
Based on network pharmacology and molecular docking to explore the molecular mechanism of Ginseng and Astragalus decoction against postmenopausal osteoporosis Wei Fan, Zong-Zhe Jiang, Sheng-Rong Wan Medicine.2023; 102(46): e35887. CrossRef
Network pharmacology-based pharmacological mechanism prediction of Lycii Fructus against postmenopausal osteoporosis Jianbo Wang, Yi Wang, Leyan Li, Shuiqi Cai, Dandan Mao, Hongkan Lou, Jian Zhao Medicine.2023; 102(48): e36292. CrossRef
Benefits of lumican on human bone health: clinical evidence using bone marrow aspirates Yun Sun Lee, So Jeong Park, Jin Young Lee, Eunah Choi, Beom-Jun Kim The Korean Journal of Internal Medicine.2022; 37(4): 821. CrossRef
ED-71 inhibited osteoclastogenesis by enhancing EphrinB2–EphB4 signaling between osteoclasts and osteoblasts in osteoporosis Yuan Zhang, Yuying Kou, Panpan Yang, Xing Rong, Rong Tang, Hongrui Liu, Minqi Li Cellular Signalling.2022; 96: 110376. CrossRef
Effects of Muscles on Bone Metabolism—with a Focus on Myokines Beom-Jun Kim Annals of Geriatric Medicine and Research.2022; 26(2): 63. CrossRef
Evaluation of the tolerability of zoledronic acid preparations for parenteral administration I. A. Shafieva, S. V. Bulgakova, A. V. Shafieva Meditsinskiy sovet = Medical Council.2022; (11): 96. CrossRef
Impact of Alendronate Sodium plus Elcatonin on Postoperative Bone Pain in Patients with Osteoporotic Fractures Baohui Wang, Yindi Sun, Da Shi, Xiuwei Han, Na Liu, Bo Wang, Zhijun Liao BioMed Research International.2022; 2022: 1. CrossRef
Current use of bone turnover markers in the management of osteoporosis Jacques P. Brown, Andrew Don-Wauchope, Pierre Douville, Caroline Albert, Samuel D. Vasikaran Clinical Biochemistry.2022; 109-110: 1. CrossRef
Study on the influence of balloon dilation mode on the intravertebral cleft of osteoporotic fracture Nanning Lv, Xiaoxiao Feng, Haojun Liu, Xuejun Jia, Shanqin Han, Mingming Liu BMC Surgery.2022;[Epub] CrossRef
An Acid-Sensitive Bone Targeting Delivery System Carrying Acacetin Prevents Osteoporosis in Ovariectomized Mice Xiaochen Sun, Chenyu Song, Chenxi Zhang, Chunlei Xing, Juan Lv, Huihui Bian, Nanning Lv, Dagui Chen, Xin Dong, Mingming Liu, Li Su Pharmaceuticals.2022; 16(1): 2. CrossRef
Changes in Serum Dickkopf-1, RANK Ligand, Osteoprotegerin, and Bone Mineral Density after Allogeneic Hematopoietic Stem Cell Transplantation Treatment Eunhee Jang, Jeonghoon Ha, Ki-Hyun Baek, Moo Il Kang Endocrinology and Metabolism.2021; 36(6): 1211. CrossRef